The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California 94143.
J Exp Med. 2014 Feb 10;211(2):245-62. doi: 10.1084/jem.20131043. Epub 2014 Feb 3.
Type I interferons (IFN-1s) are antiviral cytokines that suppress blood production while paradoxically inducing hematopoietic stem cell (HSC) proliferation. Here, we clarify the relationship between the proliferative and suppressive effects of IFN-1s on HSC function during acute and chronic IFN-1 exposure. We show that IFN-1-driven HSC proliferation is a transient event resulting from a brief relaxation of quiescence-enforcing mechanisms in response to acute IFN-1 exposure, which occurs exclusively in vivo. We find that this proliferative burst fails to exhaust the HSC pool, which rapidly returns to quiescence in response to chronic IFN-1 exposure. Moreover, we demonstrate that IFN-1-exposed HSCs with reestablished quiescence are largely protected from the killing effects of IFNs unless forced back into the cell cycle due to culture, transplantation, or myeloablative treatment, at which point they activate a p53-dependent proapoptotic gene program. Collectively, our results demonstrate that quiescence acts as a safeguard mechanism to ensure survival of the HSC pool during chronic IFN-1 exposure. We show that IFN-1s can poise HSCs for apoptosis but induce direct cell killing only upon active proliferation, thereby establishing a mechanism for the suppressive effects of IFN-1s on HSC function.
I 型干扰素(IFN-1s)是抗病毒细胞因子,可抑制血液生成,同时又反常地诱导造血干细胞(HSC)增殖。在这里,我们阐明了在急性和慢性 IFN-1 暴露期间,IFN-1 对 HSC 功能的增殖和抑制作用之间的关系。我们表明,IFN-1 驱动的 HSC 增殖是一个短暂的事件,是对急性 IFN-1 暴露的短暂放松静止维持机制的结果,这种情况仅在体内发生。我们发现,这种增殖爆发并没有耗尽 HSC 池,HSC 池会在慢性 IFN-1 暴露时迅速恢复静止。此外,我们证明,重新建立静止状态的 IFN-1 暴露 HSCs 很大程度上免受 IFNs 的杀伤作用的影响,除非由于培养、移植或骨髓清除性治疗而被迫重新进入细胞周期,此时它们会激活依赖于 p53 的促凋亡基因程序。总的来说,我们的结果表明静止是一种保护机制,可确保慢性 IFN-1 暴露期间 HSC 池的存活。我们表明,IFN-1s 可以使 HSCs 处于凋亡状态,但仅在活跃增殖时才会导致直接细胞杀伤,从而建立了 IFN-1s 对 HSC 功能的抑制作用的机制。